Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Particulate form
Patent
1993-06-14
1996-11-26
Webman, Edward J.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Particulate form
424451, 424469, 42840224, 428402, A61K 916, A61K 926, A61K 950
Patent
active
055783236
ABSTRACT:
Improved proteinoid carriers and methods for their preparation and use as oral delivery systems for pharmaceutical agents are described. The proteinoid carriers are soluble within selected pH ranges within the gastrointestinal tract and display enhanced stability towards at least one of photolysis or decomposition over time. The proteinoid carriers are prepared from proteinoids having between 2 and 20 amino acids and having a molecular weight of between about 250 and 2400 daltons.
REFERENCES:
patent: Re24899 (1960-11-01), Green
patent: 2671451 (1954-03-01), Bolger
patent: 2862918 (1958-12-01), Meyer et al.
patent: 2868740 (1959-01-01), Luce
patent: 2971916 (1961-02-01), Schleicher et al.
patent: 3016308 (1962-01-01), Macaulay
patent: 3052655 (1962-09-01), Fox et al.
patent: 3057344 (1962-10-01), Abella et al.
patent: 3076790 (1963-02-01), Fox et al.
patent: 3170802 (1965-02-01), Fukushima
patent: 3190837 (1965-06-01), Brynko et al.
patent: 3474777 (1969-10-01), Figge et al.
patent: 3491093 (1970-01-01), Pachter et al.
patent: 3565559 (1971-02-01), Sato
patent: 3567650 (1971-03-01), Bakan
patent: 3574832 (1971-04-01), Engel et al.
patent: 3576358 (1971-04-01), Hayamizu
patent: 3576758 (1971-04-01), Emrick
patent: 3725113 (1973-04-01), Chang
patent: 3748277 (1993-07-01), Wagner
patent: 3794561 (1974-02-01), Matsukawa et al.
patent: 3795739 (1974-03-01), Birkmayer et al.
patent: 3822348 (1974-07-01), Higashi et al.
patent: 3849550 (1974-11-01), Teitelbaum et al.
patent: 3937668 (1976-02-01), Zolle
patent: 3939253 (1976-05-01), Bodor et al.
patent: 3956172 (1976-02-01), Saeki et al.
patent: 3962416 (1976-06-01), Katzen
patent: 3976773 (1976-08-01), Curran
patent: 4035507 (1977-07-01), Bodor
patent: 4048268 (1977-09-01), Ludwig
patent: 4061507 (1977-12-01), Sjoholm et al.
patent: 4117801 (1978-10-01), Dannelly et al.
patent: 4147767 (1979-04-01), Yapel, Jr.
patent: 4183849 (1980-01-01), Hansen
patent: 4199561 (1980-04-01), Roth et al.
patent: 4217370 (1980-08-01), Rawlings et al.
patent: 4272506 (1981-06-01), Schwarzberg
patent: 4289759 (1981-09-01), Heavner et al.
patent: 4345588 (1982-08-01), Widder et al.
patent: 4348384 (1982-09-01), Horikoshi et al.
patent: 4351337 (1982-09-01), Sidman
patent: 4352883 (1982-10-01), Lim
patent: 4357259 (1982-11-01), Senyei et al.
patent: 4388304 (1983-06-01), Nyeki et al.
patent: 4402856 (1983-09-01), Schnoring et al.
patent: 4405598 (1983-09-01), Brown
patent: 4442090 (1984-04-01), Kakeya et al.
patent: 4446138 (1984-05-01), Pack
patent: 4450150 (1984-05-01), Sidman
patent: 4460563 (1984-07-01), Calanchi
patent: 4462839 (1984-07-01), McGinley et al.
patent: 4462991 (1984-07-01), Higuchi et al.
patent: 4473620 (1984-09-01), Wu et al.
patent: 4483807 (1984-11-01), Asano et al.
patent: 4492684 (1985-01-01), Goosen et al.
patent: 4518433 (1985-05-01), McGinley et al.
patent: 4590265 (1986-05-01), Bogan et al.
patent: 4608278 (1986-08-01), Frank
patent: 4613500 (1986-09-01), Suzuki et al.
patent: 4647455 (1987-03-01), De Bold
patent: 4666641 (1987-05-01), Fickat et al.
patent: 4671954 (1987-06-01), Goldberg
patent: 4673566 (1987-06-01), Goosen et al.
patent: 4703042 (1987-10-01), Bodor
patent: 4708952 (1987-11-01), Salatinjants
patent: 4745161 (1988-05-01), Saudek et al.
patent: 4753804 (1988-06-01), Iaccheri et al.
patent: 4757007 (1988-07-01), Satoh et al.
patent: 4757024 (1988-07-01), Roper
patent: 4757066 (1988-07-01), Shiokari et al.
patent: 4766012 (1988-08-01), Valenti
patent: 4774320 (1988-09-01), Tagliabue et al.
patent: 4789734 (1988-12-01), Pierschbacher
patent: 4835312 (1989-05-01), Itoh et al.
patent: 4837381 (1989-06-01), Steber et al.
patent: 4844904 (1989-07-01), Hamaguchi et al.
patent: 4873087 (1989-10-01), Morishita et al.
patent: 4886663 (1989-12-01), Houghten
patent: 4895725 (1990-01-01), Kantor et al.
patent: 4897444 (1990-01-01), Brynes et al.
patent: 4900730 (1990-02-01), Miyauchi
patent: 4919939 (1990-04-01), Baker
patent: 4925673 (1990-05-01), Steiner et al.
patent: 4963364 (1990-10-01), Fox et al.
patent: 4976968 (1990-12-01), Steiner
patent: 4983402 (1991-01-01), Steiner
patent: 4996292 (1991-02-01), Fox et al.
patent: 5039481 (1991-08-01), Pacifici et al.
patent: 5041291 (1991-08-01), Bader et al.
patent: 5055300 (1991-10-01), Gupta
patent: 5066487 (1991-11-01), Morelle et al.
patent: 5067961 (1991-11-01), Kelman et al.
patent: 5069936 (1991-12-01), Yen
patent: 5077278 (1991-12-01), Hafner et al.
patent: 5100669 (1992-03-01), Hyon
patent: 5100918 (1992-03-01), Sunshine et al.
patent: 5122367 (1992-06-01), Ron et al.
patent: 5126147 (1992-06-01), Silvestri et al.
patent: 5137892 (1992-08-01), Chu et al.
patent: 5186947 (1993-02-01), Goettsche et al.
patent: 5204099 (1993-04-01), Barbier et al.
patent: 5206384 (1993-04-01), Shibahara et al.
patent: 5216124 (1993-06-01), Hansen, Jr. et al.
patent: 5244653 (1993-09-01), Berke et al.
patent: 5250236 (1993-10-01), Gasco
patent: 5271961 (1993-12-01), Mathiowitz et al.
patent: 5278148 (1994-01-01), Branca et al.
patent: 5310535 (1994-05-01), Kruper et al.
patent: 5328992 (1994-07-01), Peter et al.
patent: 5352461 (1994-10-01), Feldstein et al.
patent: 5384133 (1995-01-01), Boyes et al.
patent: 5389379 (1995-02-01), Dirix et al.
patent: 5418010 (1995-05-01), Janda et al.
Robert O. Dillman, M.D., Annals of Internal Medicine 1989:111 pp. 592-600, "Monoclonal Antibodies for Treating Cancer".
Brendan D. Curti, Critical Reviews in Oncology/Hematology, 1993: 14 pp. 29-39 "Physical barriers to drug delivery in tumors".
V. Hird et al, Genes and Cancer, edited by Desmond Carney & Karol Sikora, pp. 183-189, "Immunotherapy with Monoclonal Antibodies".
Michael E. Osband et al., Immunology Today, vol. 11, No. 6 1990, pp. 93-95, "Problems in the investigational study and clinical use of cancer immunotherapy".
Tibtech Feb. 1993 vol. 11, pp. 42-44 "Therapeutic antibodies--the coming of age".
Thomas A. Waldmann, Articles Jun. 21, 1991, pp. 1657-1662, "Monoclonal Antibodies in Diagnosis and Therapy".
Airaudo, C. B., et al. (1987), Journal of Food Science 52(6):1750-1752.
Gelb, R., et al (1983), Lite Sciences 33(1):83-85.
Watterberg et al. (1988), Pediatric Research, vol. 23, No. 4, Part 2, p. 570A, column 1, abstract No. 2209.
Bernstein (1985), Chest 87(1):68S-73S.
Damage et al. (1988), Diabetes 37:246-251.
184358, Chemical Abstracts:83 (1975).
Amino, Y., et al., Chem. Pharm. Bull. 36(11):4426-4434 (1988).
Baughman, R. A. et al., Proc. of the 6th Inter'l. Symp. on Recent Advs. in Drug Delivery Systems, Ctr. for Controlled Chem. Delivery, University of Utah, Feb. 22-25, 1993, Salt Lake City UT, pp. 179-180 "Method for Assessing The Stability of Proteinoid Microspheres".
Haas, S. et al., "Assessment Of Stability Of Proteinoid Microspheres", Proceed. Intern. Symp. Control. Rel. Bioact. Mater., 20 (1993), Controlled Release Society, Inc.,.
X. Ma, et al., Proceed. Intern. Symp. Control. Rel. Bioact. Mater., 20 (1993), Controlled Release Society, Inc. "In Vitro Mechanistic Investigation of the Proteinoid Microsphere Oral Delivery System".
Yen, H.-R H., et al., "Adsorption of Sulforhodamine 101 on Proteinoid Microspheres" Proceed. Intern. Symp. Control. Rel. Bioact. Mater., 20 (1993), Controlled Release Society, Inc.
Presented at "IBC Rational Drug Design Conference", San Diego, Calif.--Dec. 1994.
Bergeron, Raymond J. et al., J. Am. Chem. Soc. 1994, 116,8479-8484 "Macromolecular Self-Assembly of Diketopiperazine Tetrapeptides".
Leone-Bay et al., Presented at "Winter Conference on Medicinal and Bioorganic Chemistry" Steamboat Springs, Colorado--Feb. 1995 Microsphere Formation and Drug Delivery in a Series of Derivatized Amino Acids.
Santiago et al., Pharm. Res. 11: 1994, p.S-298 "Oral Delivery of Heparin Microspheres made with Modified Amino Acids".
Leone-Bay et al., Pharm. Res. 11: 1994, p. S-121 "Oral Delivery of Heparin using Acylated Amino Acids".
Sarubbi et al., Pharm. Res. 11: 1994, p.S-299 "Oral Calcitonin Delivery using the PODDS Technology".
Leipold et al., Pharm. Res. 11: 1994, p.S-298 "Oral Delivery of Interferon in Rats and Primates".
Santiago et al., Pharm. Res. 11: 1994, p.S-298 "Evaluatio
Kantor Martin L.
Milstein Sam J.
Emisphere Technologies Inc.
Webman Edward J.
LandOfFree
Proteinoid carriers and methods for preparation and use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Proteinoid carriers and methods for preparation and use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Proteinoid carriers and methods for preparation and use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1971215